N-[1-[2-(1H-indol-3-yl)ethyl]-4-piperidyl]benzamide

ADVERTISEMENT

Identification

Molecular formula
C22H25N3O
CAS Number
144010-09-9
IUPAC Name
N-[1-[2-(1H-indol-3-yl)ethyl]-4-piperidyl]benzamide
Molecular Weight
349.46g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.2600g/cm3
Synonyms
INDORAMIN
Interesting facts

Interesting Facts about N-[1-[2-(1H-indol-3-yl)ethyl]-4-piperidyl]benzamide

N-[1-[2-(1H-indol-3-yl)ethyl]-4-piperidyl]benzamide is a fascinating compound that captures the interest of scientists across various fields due to its intriguing structure and potential applications. Below are some compelling aspects of this compound:

  • Pharmacological Relevance: This compound has been studied for its potential use in neurological therapeutics. Its indole structure is particularly notable, as indoles are found in many biologically active compounds, including neurotransmitters.
  • Structural Complexity: The presence of both indole and piperidine rings contributes to its structural diversity, making it a fascinating subject for studies in medicinal chemistry.
  • Research Potential: Numerous studies aim to evaluate the compound's efficacy as a drug candidate, particularly in targeting specific receptors in the brain, which could lead to advancements in treating disorders such as depression or anxiety.
  • Hybrid Architecture: The unique combination of the piperidine and benzamide moieties offers intriguing possibilities for modifying its pharmacophore, enhancing its activity or selectivity towards certain biological targets.
  • Natural Compounds Inspiration: Indole derivatives like this compound often mimic structures found in nature, showcasing how natural products inspire synthetic chemistry and drug design.

In summary, N-[1-[2-(1H-indol-3-yl)ethyl]-4-piperidyl]benzamide stands out as a compound with significant potential in medicinal chemistry, driven by its unique structural characteristics and alignment with pharmacologically active frameworks. Its continuous exploration could pave the way for future therapeutic agents.

ADVERTISEMENT